Grigore A

Idioma: Ingles.
Referencias bibliográficas: 19
Paginas: 302-304
Archivo PDF: 617.38 Kb.

FRAGMENTO

Sin resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. American Heart Association. Heart disease and stroke statistics–2009 Update. Dallas, Texas: American Heart Association; 2009.

2. Renlund DG, Kfoury AG. When the failing, end-stage heart is not end-stage. N Engl J Med 2006;355:1922-5.

3. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circulation 2001;104:2996-3007.

4. Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 2006;104:556-69.

5. Pinski SL. Continuing progress in the treatment of severe congestive heart failure. JAMA 2003;289:754-6.

6. Miller LW, Lietz K. Candidate selection for long-term left ventricular assist device therapy for refractory heart failure. J Heart Lung Transplant 2006;25:756-64.

7. Treschan TA, Peters J. The vasopressin system. Anesthesiology 2006;105:599-612.

8. Shanmugam G. Vasoplegic syndrome–the role of methylene blue. Eur J Cardiothorac Surg 2005;28:705-10.

9. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report–2004. J Heart Lung Transplant 2004;23:796-803.

10. Frazier OH, Gregoric ID, Cohn WE. Surgical treatment of advanced heart failure. In: Willerson JT, Cohn JN, Wellens HJJ, Holmes DR, eds. Cardiovascular Medicine. 3rd ed. New York, NY: Springer; 2007:1461-78.

11. Stevenson LW, Rose EA. Left ventricular assist devices: bridges to transplantation, recovery, and destination for whom? Circulation 2003;108:3059-63.

12. Kirklin JK, Holman WL. Mechanical circulatory support therapy as a bridge to transplant or recovery (new advances). Curr Opin Cardiol 2006;21:120-6.

13. Lietz K, Miller LW. Will left-ventricular assist device therapy replace heart transplantation in the foreseeable future? Curr Opin Cardiol 2005;20:132-7.

14. Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355:1873-84.

15. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease. I. Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 2008;117:1436-48.

16. Haddad F, Doyle R, Murphy DJ. Hunt SA. Right ventricular function in cardiovascular disease. II. Pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008;117:1717-31.

17. Kaul TK, Fields BL. Postoperative acute refractory right ventricular failure: incidence, pathogenesis, management and prognosis. Cardiovasc Surg 2000;8:1-9.

18. Haddad F, Couture P, Tousignant C, Demnault AY. The right ventricle in cardiac surgery, a perioperative perspective: I. Anatomy, physiology, and assessment. Anesth Analg 2009;108:407-21.

19. Haddad F, Coutoure P, Tousignant C, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: II. Pathophysiology, clinical importance, and management. Anesth Analg 2009;108:422-33.